Axa’s Houlihan Lokey HLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,307
Closed -$619K 62
2026
Q1
$619K Sell
4,307
-430
-9% -$70.7K 0.24% 57
2025
Q4
$825K Buy
+4,737
New +$869K 0.39% 50
2023
Q2
Sell
-7,200
Closed -$630K 1115
2023
Q1
$630K Hold
7,200
﹤0.01% 937
2022
Q4
$628K Sell
7,200
-2,500
-26% -$225K ﹤0.01% 957
2022
Q3
$731K Sell
9,700
-8,600
-47% -$697K ﹤0.01% 910
2022
Q2
$1.44M Sell
18,300
-46,200
-72% -$3.86M 0.01% 823
2022
Q1
$5.66M Buy
64,500
+43,400
+206% +$4.47M 0.02% 614
2021
Q4
$2.18M Buy
21,100
+3,100
+17% +$331K 0.01% 828
2021
Q3
$1.66M Buy
18,000
+9,400
+109% +$824K ﹤0.01% 894
2021
Q2
$703K Hold
8,600
﹤0.01% 1058
2021
Q1
$572K Buy
+8,600
New +$580K ﹤0.01% 1062

Other funds holding HLI

Axa's HLI Position: Q2 2026 in Review

Axa sold out of Houlihan Lokey (HLI) in Q2 2026, closing a stake of 4,307 shares — an estimated $619K sold.

Axa first reported a position in HLI in Q1 2021 and held it in 11 quarters. The position peaked at $5.66M in Q1 2022. 518 funds tracked by Wall St. Rank hold HLI as of Q2 2026.

  • Axa reported no remaining Houlihan Lokey position as of Q2 2026 after selling out during the quarter.
  • Axa sold 4,307 Houlihan Lokey shares in Q2 2026, an estimated $619K.
  • Axa first reported a position in Houlihan Lokey in Q1 2021 and held it in 11 quarters.
  • Axa's Houlihan Lokey position peaked at $5.66M in Q1 2022.
  • 518 funds tracked by Wall St. Rank held Houlihan Lokey as of Q2 2026.

Based on Axa's 13F filing for Q2 2026, filed 14 Aug 2026.